ePRO-supported monitoring and chemotherapy dose intensity in early-stage breast cancer: a retrospective study dataset

Published: 16 July 2025| Version 2 | DOI: 10.17632/w2g7hd47b4.2
Contributor:
Yuki Takei

Description

This de-identified dataset supports a retrospective analysis of ePRO use and chemotherapy intensity in early-stage breast cancer.

Files

Steps to reproduce

This dataset was used to evaluate the association between ePRO use and chemotherapy dose intensity (ARDI) and adverse events. Statistical analyses were performed using JMP® Pro 17.0.0. ARDI was calculated using the formula described in the related manuscript. See README file for variable definitions.

Institutions

  • Teikyo Daigaku Igakubu Fuzoku Byoin

Categories

Oncology, Breast Cancer, Clinical Pharmacy, Electronic Patient Record

Licence